Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03069443
Other study ID # POTENT
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 15, 2017
Est. completion date July 9, 2020

Study information

Verified date July 2020
Source Aalborg University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This Study evaluates the effect of 20 weeks of isometric handgrip (IHG) home training in adults aged 50 years or more. Half of the participants will serve as a control group and will only receive hypertension-guidelines on lifestyle changes.


Description:

Hypertension markedly increases the risk of cardiovascular diseases and overall mortality. Lifestyle modifications such as increased levels of physical activity are recommended as the first line of anti-hypertensive treatment. A recent systematic review showed that isometric handgrip (IHG) training was superior to traditional endurance and strength training in lowering resting systolic blood pressure (SBP). The average length of previous IHG training studies is approximately 7.5 weeks with the longest being 10 weeks. Therefore, presently it is unknown if it is possible to further lower blood pressure levels beyond the 10 week mark. Recently, the investigators developed a novel method for monitoring handgrip intensity using a standard Nintendo Wii Board (Wii). The primary aim of this study is to explore the effects of 20-weeks IHG home training facilitated by a Wii in hypertensive older adults (+50 years of age) in lowering SBP compared to usual care. Secondary aims are to explore if/when a leveling off effect on SBP will occur during the 20-week intervention period in the training group and to explore adherence and potential harms related to the IHG home training.

Methods: Based on previous evidence, the investigators calculated that 50 hypertensive older adults (+50 years of age) is needed to achieve a power of 80% or more. Participants will be randomly assigned to either an intervention group (IHG home training + hypertension-guidelines on lifestyle changes) or to a control group (hypertension-guidelines on lifestyle changes). Participants in the intervention group will perform IHG home training (30% of maximum grip strength for a total of 8 min per day per hand) three times a week for 20-weeks.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date July 9, 2020
Est. primary completion date July 9, 2020
Accepts healthy volunteers No
Gender All
Age group 50 Years to 120 Years
Eligibility Inclusion Criteria:

1. Age +50 years old

2. Un-medicated (anti-hypertensive medicine) with resting SBP between 135-179 mmHg or hypertensive patient medicated with no change in treatment for = 4 months with resting SBP between 135-179 mmHg

Exclusion Criteria:

1. Manifest cardiovascular disease (cerebrovascular disease, Heart failure, Chronic Kidney Disease, peripheral vascular disease, and advanced retinopathy (fundus hypertonus III-IV)).

2. Diabetes (any type)

3. More than three blood pressure regulating agents

4. Physical limitation preventing IHG training (e.g. missing an arm or musculoskeletal disorders).

5. Arthritis in the hand or carpal tunnel

6. SBP = 180 mmHg (will be advised to see a doctor)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
IHG home training
Participants of the intervention group will follow the IHG home training protocol for 20 weeks. The IHG training consists of isometric contractions applied with the hands on a Wii.

Locations

Country Name City State
Denmark Aalborg University hospital Aalborg Danmark

Sponsors (3)

Lead Sponsor Collaborator
Aalborg University Hospital Aalborg University, Odense University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Systolic blood pressure measured using a standard hospital electrical sphygmomanometer (Omron Comfort M6 AC) after 20 weeks of training
Secondary Diastolic blood pressure measured using a standard hospital electrical sphygmomanometer (Omron Comfort M6 AC) after 20 weeks of training
Secondary heart rate measured using a standard hospital electrical sphygmomanometer (Omron Comfort M6 AC) after 20 weeks of training
Secondary Handgrip maximum strength This will be measured using the WII and reported in kilograms in the FysioMeter software baseline, 5 week, 15 weeks, and 20 weeks followup
Secondary Handgrip Rate of force development measured using a specially designed software working together with a standard wii board. baseline, 5 week, 15 weeks, and 20 weeks followup
Secondary Handgrip Force variability This will be a measure of the muscle force variability during the isometric training sessions throughout the study after 20 weeks of training
Secondary Visual Analog Pain Scale (VAS) At the end of each training session. Pain will be assessed for each hand/side using the VAS scale after 20 weeks of training
Secondary Compliance to training sessions A report will be generated on how many sessions each participant have completed during the study after 20 weeks of training
Secondary Systolic blood pressure measured using a standard hospital electrical sphygmomanometer (Omron Comfort M6 AC) week 25, 35, and 40 post-intervention
Secondary Diastolic blood pressure measured using a standard hospital electrical sphygmomanometer (Omron Comfort M6 AC) week 25, 35, and 40 post-intervention
Secondary heart rate measured using a standard hospital electrical sphygmomanometer (Omron Comfort M6 AC) week 25, 35, and 40 post-intervention
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A